" class="wow_main_float_head_img">
Biobanking Industry Data Book Covers Biobanks, Cell Banking Outsourcing, Cord Blood Banking Services, DNA RNA Banking Services Markets.
Grand View Research’s Biobanking Industry databook is a collection of market sizing forecasts insights, market dynamics trends, opportunity assessment, regulatory technology framework, pricing intelligence, competitive benchmarking analyses, macro-environmental analyses studies. Within the purview of the databook, such information is systematically analyzed and provided in the form of summary presentations and detailed outlook reports on individual areas of research.
Biobanks Market Insights
The global biobanks market size was valued at USD 71.4 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 8.6% from 2023 to 2030.
On the basis of products, the global market has been further sub-segmented into biobanking equipment, biobanking consumables, and laboratory information management systems (LIMS). The biobanking equipment segment dominated the market and accounted for the largest revenue share of 77.1% in 2022 owing to a rapid increase in the number of new biobanks and the high cost of initial equipment installation.
On the basis of services, the global market has been further sub-segmented into biobanking repository, lab processing, qualification/validation, cold chain logistics, and other services. The biobanking and repository services segment dominated the market and accounted for the largest share of more than 32.3% of the global revenue in 2022. This is owing to the higher market penetration of these services and the increased need for the preservation of biosamples for developing precision medicine and disease-specific research.
On the basis of biospecimen types, the global market has been categorized into human tissues, organs, stem cells, and other biospecimens. The human tissues segment dominated the market and accounted for the largest revenue share of 36.5% in 2022.
On the basis of biobank types, the global market has been further bifurcated into physical/real biobanks and virtual biobanks. The physical/real biobanks segment dominated the market in 2022 and accounted for the largest revenue share of 76.6%. These biobanks have a well-established network, thereby holding a high revenue share.
On the basis of applications, the market has been further categorized into therapeutics, drug discovery clinical research, clinical diagnostics, and other applications. In 2022, the therapeutics application segment dominated the market with a revenue share of 34.1%. This can be attributed to the ever-increasing demand for advanced therapies for the treatment of chronic diseases.
Cell Banking Outsourcing Market Insights
The global cell banking outsourcing market size was computed at USD 9,869.5 million in 2021 and is anticipated to exhibit a compound annual growth rate (CAGR) of 16.39% from 2022 to 2030.
Master cell banking accounted for the largest share of revenue in 2021, as their preparation is a prerequisite for the production and usage of working cell banks. They are preserved for a significantly longer duration, which also attracts the application of high-grade cryopreservation methodologies and equipment thereby further expanding the revenue base for this segment.
Stem cells segment dominated the market with a share of 55.3%in 2021. Stem cells are obtained from cord blood, embryonic, adult, dental, and IPS cells, while non-stem include somatic cells preserved for applications such as tissue engineering and IPS cell development. An increase in research and development activities associated with the applications of stem cells drives the segment growth.
Based on phase, the market is segmented into bank storage, bank characterization and testing, and bank preparation. Of these, storage accounted for the largest share of revenue owing to sophisticated preservation needs which are essential for proper maintenance of either master or working banks. Additionally, technologically advanced cryopreservation techniques are expected to fuel the growth of this market throughout the forecast period.
Access the Global Biobanking Industry Data Book, 2022 to 2030, compiled with details like market sizing information forecasts, trade data, pricing intelligence, competition benchmarking, macro-environmental analyses, and regulatory technological framework studies
Cord Blood Banking Services Market Insights
The global cord blood banking services market size was valued at USD 29.7 billion in 2016 and is expected to grow at a CAGR of 11.9% over the forecast period.
Globally three types of cord blood banks: public, private, and hybrid are available. Private banks captured the largest revenue share in 2016 owing to the high cost associated with collection and storage of CB units charged to parents. Moreover, the marketing activities practiced by the private players are resulting in the increased customer base of private players compared to public banks. Considering all the above-mentioned factors together, the private banking service segment was leading the global market.
DNA RNA Banking Services Market Insights
The global DNA and RNA banking services market size was valued at USD 6.09 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 5.46% from 2021 to 2027.
Storage service dominated the market with a revenue share of 35.9% in 2020. The acquisition of high-quality biospecimens is vital for researchers. Reliable long-term stabilization and storage of DNA and RNA are critical for the success of biobanks. It is essential to store biological samples in fully qualified, temperature-controlled storage, such as -196 °C; -80 °C; -20 °C; 2.0 °C-8.0 °C; and 15.0 °C-25.0 °C.
The blood segment accounted for the largest share of 39.8% in 2020as it is the most recommended sample type for routine care applications. It is proven to be the most popular specimen type for non-invasive biomarker-based cancer studies. In addition, the time of collecting blood samples does not impact the yield of DNA and RNA.
In terms of revenue, drug discovery and clinical research accounted for the largest revenue share of 37.2% in 2020 as DNA and RNA banking services support the scientific progress in the stratification of population and biomarker discovery. These services are important for new drug discovery and clinical research processes. It helps support the entire procedure of patient prevention and prediction, therapy monitoring, follow-up, and therapy optimization.
The academic research segment dominated the DNA and RNA banking services market with a revenue share of 32.8% in 2020. The value of DNA and RNA biobanks is well recognized by translational researchers at academic institutions and laboratories.
Biobanking Market – Global Industry Segmentation
Biobanks Industry, By Product
- Biobanking Equipment
- Temperature Control Systems
- Freezers Refrigerators
- Cryogenic Storage Systems
- Thawing Equipment
- Incubators Centrifuges
- Alarms Monitoring Systems
- Accessories Other Equipment
- Temperature Control Systems
- Biobanking Consumables
- Laboratory Information Management Systems
Biobanks Industry, By Service
- Biobanking Repository
- Lab processing
- Qualification/ Validation
- Cold Chain Logistics
- Other Service
Biobanks Industry, By Biospecimen Type
- Human Tissues
- Organs
- Stem Cells
- Adult Stem Cells
- Embryonic Stem Cells
- IPS Cells
- Other Stem Cells
- Other Biospecimens
Biobanks Industry, By Type
- Physical/Real Biobanks
- Tissue Biobanks
- Population Based Biobanks
- Genetic (DNA/RNA)
- Disease Based Biobanks
- Virtual Biobanks
Biobanks Industry, By Application
- Therapeutics
- Drug Discovery Clinical Research
- Clinical Diagnostics
- Other Application
Cell Banking Outsourcing Industry, By Type
- Master Cell Banking
- Working Cell Banking
- Viral Cell Banking
Cell Banking Outsourcing Industry, By Cell Type
- Stem Cell
- Cord Cell Banking
- Embryonic Stem Cell Banking
- Adult Stem Cell Banking
- Dental Stem Cell Banking
- IPS Stem Cell Banking
- Non-stem Cell
Cell Banking Outsourcing Industry, By Phase
- Bank Storage
- Master Cell Bank Prep.
- Working Cell Bank Prep.
- Cell Storage Stability Testing
- Bank Characterization Testing
- Safety Testing
- Viral Cell Banks
- Microbial Cell Banks
- Gene Expression Testing
- Karyology Testing
- Gene Sequencing Testing
- Safety Testing
- Bank Preparation
- Master Cell Bank Prep
- Working Cell Bank Prep
Cord Blood Banking Services Industry, By Bank Type
- Private
- Public
- Hybrid
DNA RNA Banking Services Industry, By Type
- Transportation Service
- Processing Service
- Storage Service
- Quality Control Service
- Data Storage
- Others
DNA RNA Banking Services Industry, By Specimen Type
- Blood
- Buccal Swabs Hair Follicles
- Others
DNA RNA Banking Services Industry, By Application
- Therapeutics
- Drug Discovery Clinical Research
- Clinical Diagnostics
- Other Applications
DNA RNA Banking Services Industry, By End-use
- Academic Research
- Pharmaceutical Biotechnology Companies
- Hospitals Diagnostic Centers
- Others
Order your copy of the Free Sample of “Biobanking Industry Data Book - Biobanks, Cell Banking Outsourcing, Cord Blood Banking Services, DNA RNA Banking Services Market Size, Share, Trends Analysis, And Segment Forecasts, 2023 - 2030” Data Book, published by Grand View Research
Biobanking Industry Data Book Regional Outlook
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- France
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Singapore
- Australia
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East Africa (MEA)
- South Africa
- United Arab Emirates
- Saudi Arabia
- Rest of Middle East Africa
Biobanking Industry Data Book Competitive Landscape
Competitive rivalry in the biobanking industry is high due to the presence of a large number of both well-established players and small- to mid-sized companies as well as biobanks in the market space.
Key players operating in the biobanking industry are –
- Thermo Fisher Scientific Inc.
- Charles River Laboratories
- Merck KGaA
- Cord Blood America, Inc.
- Becton
- Dickinson and Company
- Cryo-Cell International, Inc
- PromoCell GmbH
- SGS Life Sciences
- Lonza Group AG
Go through the table of content of Biobanking Industry Data Book to get a better understanding of the Coverage Scope of the study
About Grand View Research
Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: sales@grandviewresearch.com
Web: https://www.grandviewresearch.com/sector-reports-list
